Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Virtual Phase 2 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of the Combination of Famotidine and Celecoxib as a Post-exposure Prophylaxis (PEP) for Newly-infected COVID-19 Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05077969
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:23.761559+00:00
Published At
2024-07-09T00:00:00+00:00
Record Updated At
2024-07-09
Results Posted At
2024-07-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["2019 Novel Coronavirus Disease", "2019 Novel Coronavirus Infection", "2019-nCoV Disease", "2019-nCoV Infection", "COVID-19", "COVID-19 Pandemic", "COVID-19 Virus Disease", "COVID-19 Virus Infection", "Covid19", "Coronavirus Disease 2019", "SARS-CoV2 Infection", "SARS-CoV-2 Acute Respiratory Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-09"
protocolSection.identificationModule.nctId
"NCT05077969"
protocolSection.identificationModule.officialTitle
"A Virtual Phase 2 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of the Combination of Famotidine and Celecoxib as a Post-exposure Prophylaxis (PEP) for Newly-infected COVID-19 Patients"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-07-09"

Study condition terms

  • 2019 Novel Coronavirus Disease (protocolSection.conditionsModule.conditions)
  • 2019 Novel Coronavirus Infection (protocolSection.conditionsModule.conditions)
  • 2019-nCoV Disease (protocolSection.conditionsModule.conditions)
  • 2019-nCoV Infection (protocolSection.conditionsModule.conditions)
  • COVID-19 (protocolSection.conditionsModule.conditions)
  • COVID-19 Pandemic (protocolSection.conditionsModule.conditions)
  • COVID-19 Virus Disease (protocolSection.conditionsModule.conditions)
  • COVID-19 Virus Infection (protocolSection.conditionsModule.conditions)
  • Covid19 (protocolSection.conditionsModule.conditions)
  • Coronavirus Disease 2019 (protocolSection.conditionsModule.conditions)
  • SARS-CoV2 Infection (protocolSection.conditionsModule.conditions)
  • SARS-CoV-2 Acute Respiratory Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.